These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


331 related items for PubMed ID: 12094616

  • 1. Carnosic acid inhibits proliferation and augments differentiation of human leukemic cells induced by 1,25-dihydroxyvitamin D3 and retinoic acid.
    Steiner M, Priel I, Giat J, Levy J, Sharoni Y, Danilenko M.
    Nutr Cancer; 2001; 41(1-2):135-44. PubMed ID: 12094616
    [Abstract] [Full Text] [Related]

  • 2. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
    Shiohara M, Uskokovic M, Hisatake J, Hisatake Y, Koike K, Komiyama A, Koeffler HP.
    Cancer Res; 2001 Apr 15; 61(8):3361-8. PubMed ID: 11309293
    [Abstract] [Full Text] [Related]

  • 3. Synergistic effects of curcumin on all-trans retinoic acid- and 1 alpha,25-dihydroxyvitamin D3-induced differentiation in human promyelocytic leukemia HL-60 cells.
    Liu Y, Chang RL, Cui XX, Newmark HL, Conney AH.
    Oncol Res; 1997 Apr 15; 9(1):19-29. PubMed ID: 9112257
    [Abstract] [Full Text] [Related]

  • 4. Carnosic acid potentiates the antioxidant and prodifferentiation effects of 1alpha,25-dihydroxyvitamin D3 in leukemia cells but does not promote elevation of basal levels of intracellular calcium.
    Danilenko M, Wang Q, Wang X, Levy J, Sharoni Y, Studzinski GP.
    Cancer Res; 2003 Mar 15; 63(6):1325-32. PubMed ID: 12649194
    [Abstract] [Full Text] [Related]

  • 5. Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells.
    Wang QM, Jones JB, Studzinski GP.
    Cancer Res; 1996 Jan 15; 56(2):264-7. PubMed ID: 8542578
    [Abstract] [Full Text] [Related]

  • 6. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M, Koshizuka K, Kawabata H, Yang R, Taub HE, Said J, Uskokovic M, Tsuruoka N, Koeffler HP.
    Anticancer Res; 1999 Jan 15; 19(3A):1689-97. PubMed ID: 10470102
    [Abstract] [Full Text] [Related]

  • 7. Carnosic acid and promotion of monocytic differentiation of HL60-G cells initiated by other agents.
    Danilenko M, Wang X, Studzinski GP.
    J Natl Cancer Inst; 2001 Aug 15; 93(16):1224-33. PubMed ID: 11504768
    [Abstract] [Full Text] [Related]

  • 8. Pyranocoumarins isolated from Peucedanum praeruptorum as differentiation inducers in human leukemic HL-60 cells.
    Zhang JX, Fong WF, Wu JY, Yang M, Cheung HY.
    Planta Med; 2003 Mar 15; 69(3):223-9. PubMed ID: 12677525
    [Abstract] [Full Text] [Related]

  • 9. Retinoic acid and the cyclin dependent kinase inhibitors synergistically alter proliferation and morphology of U343 astrocytoma cells.
    Dirks PB, Patel K, Hubbard SL, Ackerley C, Hamel PA, Rutka JT.
    Oncogene; 1997 Oct 23; 15(17):2037-48. PubMed ID: 9366521
    [Abstract] [Full Text] [Related]

  • 10. Carnosic acid inhibits the growth of ER-negative human breast cancer cells and synergizes with curcumin.
    Einbond LS, Wu HA, Kashiwazaki R, He K, Roller M, Su T, Wang X, Goldsberry S.
    Fitoterapia; 2012 Oct 23; 83(7):1160-8. PubMed ID: 22828666
    [Abstract] [Full Text] [Related]

  • 11. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
    Elstner E, Linker-Israeli M, Umiel T, Le J, Grillier I, Said J, Shintaku IP, Krajewski S, Reed JC, Binderup L, Koeffler HP.
    Cancer Res; 1996 Aug 01; 56(15):3570-6. PubMed ID: 8758928
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [G1 block of the cell cycle during differentiation of F9 cells correlates with accumulation of inhibitors of the activity of cyclin-kinase complexes of proteins p21/Waf1 and p27/Kip].
    Malashicheva AB, Kisliakova TV, Pospelov VA.
    Tsitologiia; 2002 Aug 01; 44(7):649-55. PubMed ID: 12455373
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Retinoic acid causes cell growth arrest and an increase in p27 in F9 wild type but not in F9 retinoic acid receptor beta2 knockout cells.
    Li R, Faria TN, Boehm M, Nabel EG, Gudas LJ.
    Exp Cell Res; 2004 Mar 10; 294(1):290-300. PubMed ID: 14980522
    [Abstract] [Full Text] [Related]

  • 18. 19-nor vitamin-D analogs: a new class of potent inhibitors of proliferation and inducers of differentiation of human myeloid leukemia cell lines.
    Asou H, Koike M, Elstner E, Cambell M, Le J, Uskokovic MR, Kamada N, Koeffler HP.
    Blood; 1998 Oct 01; 92(7):2441-9. PubMed ID: 9746784
    [Abstract] [Full Text] [Related]

  • 19. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells.
    Agarwal C, Singh RP, Dhanalakshmi S, Tyagi AK, Tecklenburg M, Sclafani RA, Agarwal R.
    Oncogene; 2003 Nov 13; 22(51):8271-82. PubMed ID: 14614451
    [Abstract] [Full Text] [Related]

  • 20. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
    Ozpolat B, Akar U, Steiner M, Zorrilla-Calancha I, Tirado-Gomez M, Colburn N, Danilenko M, Kornblau S, Berestein GL.
    Mol Cancer Res; 2007 Jan 13; 5(1):95-108. PubMed ID: 17259349
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.